Loading

From Fragmentation to Flywheel: Why South Florida Could Be the Next Strategic Biotech Hub

March 02, 2026
Type: Innovation Stage
As biotech companies compete for talent, capital, and speed to value, geographic strategy has become a source of competitive advantage. South Florida has experienced an influx of seasoned operators, rapid expansion of research capabilities across multiple universities, and increasing engagement from both traditional and alternative capital providers. This discussion will examine what is drawing companies and leaders to the region — including operational efficiency, talent arbitrage, access to family office and international capital, and a more coordinated academic ecosystem. Can these factors translate into a durable competitive edge outside legacy hubs — and what must align to convert momentum into a true ecosystem flywheel?
Moderator
Raquel Cabo
Founder
Miami Biotech Collective
Speakers
Mani Foroohar
Senior Managing Director, Genetic Medicines
Leerink Partners
Kerri-Ann Miller
Chief Financial Officer
Syncromune
William Silverman
Executive Director, Coulter Program & New Ventures
University of Miami
Steve Squinto
Chief Investment Officer
J.P. Morgan Life Science Private Capital
Lucy To
EVP & Chief Financial Officer
SAB Bio